North America Cardiac Microcatheter Market Forecast to 2028 - Regional Analysis - by Indication (General Peripheral Vascular and Coronary) and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers)

North America Cardiac Microcatheter Market Forecast to 2028 - Regional Analysis - by Indication (General Peripheral Vascular and Coronary) and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers)

The North America cardiac microcatheter market is expected to grow from US$ 134.79 million in 2023 to US$ 188.10 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2023 to 2028.

Increasing Prevalence of Cardiovascular Diseases Fuel North America Cardiac Microcatheter Market

According to the World Health Organization (WHO), cardiovascular diseases are the most prominent cause of morbidity and mortality worldwide. cardiovascular diseases include cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Major lifestyle factors causing cardiovascular diseases and related difficulties are tobacco consumption, unhealthy diet, and physical inactivity, among others. The other risk factors related to cardiovascular diseases are high blood pressure, diabetes, and elevated cholesterol levels. Heart attacks and strokes are mainly caused by fatty deposits that block blood vessels, disrupting blood flow to the heart or brain. According to a report from American Heart Association, in 2020, ~19 million deaths were attributed to cardiovascular diseases globally, which amounted to an increase of 18.7% from 2010. Ischemic heart disease was the most common cause of cardiovascular mortality, claiming more than 9.4 million lives and 185 million disability-adjusted life-years in 2020, while ischemic stroke, intracerebral hemorrhage, hypertensive heart disease, and rheumatic heart disease rounded out to be the top 5 leading causes. According to American Heart Association Inc., the cardiovascular diseases -related deaths recorded in 2020 increased to 928,741 from 874,613 in 2019. Between 2018 and 2019, direct and indirect costs of total cardiovascular diseases were US$ 407.3 billion (US$ 251.4 billion in direct costs and US$ 155.9 billion in lost productivity/mortality). In 2020, coronary heart disease was the leading cause (41.2%) of deaths attributable to cardiovascular diseases in the US, followed by stroke (17.3%), high blood pressure (12.9%), heart failure (9.2%), diseases of the arteries (2.6%), and other cardiovascular diseases (16.8%). Also, the World Heart Federation predicts more than 23 million cardiovascular diseases -related deaths per year by 2030. Therefore, the high prevalence of cardiovascular diseases is boosting the North America cardiac microcatheter market.

North America Cardiac Microcatheter Market Overview

The North America cardiac microcatheter market is segmented into the US, Canada, and Mexico. The market growth in countries such as the US and Canada is driven by factors such as increasing incidence of heart diseases, including cardiovascular disorders, stroke, and others, coupled with well-developed healthcare infrastructure.

North America Cardiac Microcatheter Market Revenue and Forecast to 2028 (US$ Million)

North America Cardiac Microcatheter Market Segmentation

The North America cardiac microcatheter market is segmented into indication, end user, and country.

Based on indication, the North America cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held a larger share of the North America cardiac microcatheter market in 2023.

Based on end user, the North America cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the North America cardiac microcatheter market in 2023.

Based on country, the North America cardiac microcatheter market is segmented into the US, Canada, and Mexico. The US dominated the share of the North America cardiac microcatheter market in 2023.

Asahi Intecc USA Inc; Boston Scientific Corp; Integer Holdings Corp; Medtronic Plc; Merit Medical Systems Inc; Nipro Corp; Teleflex Inc; and Terumo Corp are the leading companies operating in the North America cardiac microcatheter market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America cardiacmicrocatheter market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America cardiacmicrocatheter market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.